TY - JOUR
T1 - Late-Onset Depression but not Early-Onset Depression may Increase the Risk of All-Cause Mortality in Older Age: 8-Year Follow-Up of the Salus in Apulia Study
AU - Lozupone, Madia
AU - Castellana, Fabio
AU - Sardone, Rodolfo
AU - Berardino, Giuseppe
AU - Mollica, Anita
AU - Zupo, Roberta
AU - De Pergola, Giovanni
AU - Griseta, Chiara
AU - Stallone, Roberta
AU - La Montagna, Maddalena
AU - Dibello, Vittorio
AU - Seripa, Davide
AU - Daniele, Antonio
AU - Altamura, Mario
AU - Solfrizzi, Vincenzo
AU - Bellomo, Antonello
AU - Panza, Francesco
PY - 2023
Y1 - 2023
N2 - Objectives: Individuals with late-life depression (LLD) may have shorter survival, but there is a lack of findings in population-based settings about health-related outcomes of LLD and its subtypes: early-onset depression (EOD) and late-onset depression (LOD). We aimed to evaluate the risk of all-cause mortality of individuals with LLD and its subtypes in an older population-based cohort. Moreover, we investigated whether inflammatory, cognitive, genetic features and multimorbidity could modify the effect of this association. Design: Longitudinal population-based study with 8-year follow-up. Setting and participants: We analyzed data on a sample of 1479 participants, all aged >65 years, in the Salus in Apulia Study. Methods: LLD was diagnosed through DSM-IV-TR criteria and LOD and EOD according to the age of onset. Multimorbidity status was defined as the copresence of 2 or more chronic diseases. Results: The overall prevalence of LLD in this older sample from Southern Italy was 10.2%, subdivided into 3.4% EOD and 6.8% LOD. In multivariable Cox models adjusted for age, gender, education, global cognition, apolipoprotein E ε4 allele, physical frailty, interleukin-6, and multimorbidity, LLD showed a greater risk of all-cause mortality. LOD differed from EOD regarding gender, education, cognitive dysfunctions, and diabetes mellitus. There was a significantly increased risk of all-cause mortality for participants with LOD (hazard ratio:1.99; 95% CI 1.33-2.97) in the time of observation between enrollment date and death date (7.31 ± 2.17 months). Conclusions and implication: In older age, individuals with LOD but not with EOD had a significantly decreased survival, probably related to increased inflammation, multimorbidity, and cognitive impairments.
AB - Objectives: Individuals with late-life depression (LLD) may have shorter survival, but there is a lack of findings in population-based settings about health-related outcomes of LLD and its subtypes: early-onset depression (EOD) and late-onset depression (LOD). We aimed to evaluate the risk of all-cause mortality of individuals with LLD and its subtypes in an older population-based cohort. Moreover, we investigated whether inflammatory, cognitive, genetic features and multimorbidity could modify the effect of this association. Design: Longitudinal population-based study with 8-year follow-up. Setting and participants: We analyzed data on a sample of 1479 participants, all aged >65 years, in the Salus in Apulia Study. Methods: LLD was diagnosed through DSM-IV-TR criteria and LOD and EOD according to the age of onset. Multimorbidity status was defined as the copresence of 2 or more chronic diseases. Results: The overall prevalence of LLD in this older sample from Southern Italy was 10.2%, subdivided into 3.4% EOD and 6.8% LOD. In multivariable Cox models adjusted for age, gender, education, global cognition, apolipoprotein E ε4 allele, physical frailty, interleukin-6, and multimorbidity, LLD showed a greater risk of all-cause mortality. LOD differed from EOD regarding gender, education, cognitive dysfunctions, and diabetes mellitus. There was a significantly increased risk of all-cause mortality for participants with LOD (hazard ratio:1.99; 95% CI 1.33-2.97) in the time of observation between enrollment date and death date (7.31 ± 2.17 months). Conclusions and implication: In older age, individuals with LOD but not with EOD had a significantly decreased survival, probably related to increased inflammation, multimorbidity, and cognitive impairments.
KW - Late-onset depression
KW - frailty
KW - interleukin-6
KW - neuroinflammation
KW - population-based
KW - survival
KW - Late-onset depression
KW - frailty
KW - interleukin-6
KW - neuroinflammation
KW - population-based
KW - survival
UR - https://publicatt.unicatt.it/handle/10807/257909
UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85146355870&origin=inward
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85146355870&origin=inward
U2 - 10.1016/j.jamda.2022.12.005
DO - 10.1016/j.jamda.2022.12.005
M3 - Article
SN - 1538-9375
VL - 24
SP - 679
EP - 687
JO - Journal of the American Medical Directors Association
JF - Journal of the American Medical Directors Association
IS - 5
ER -